Non-liver mRNA Delivery
Abstract
Conspectus mRNA drugs can preempt infectious disease and treat Mendelian disorders, such as sickle cell anemia, muscular dystrophy, and cystic fibrosis, as well as autoimmunity and cancer. The three major therapeutic areas for which mRNA delivery is currently being explored are antigen production, including the COVID-19 vaccine, protein replacement therapy, and genome engineering. It was demonstrated 30 years ago that introducing in vitro transcribed mRNA intramuscularly results in detectable protein expression for specific antigens protecting against the likes of influenza and cancer. Utilizing mRNA as a therapeutic modality, however, is challenging. mRNA is large and anionic and, as a result, cannot passively diffuse across the negatively charged plasma membrane. In addition, RNases present in the bloodstream and tissues rapidly degrade mRNA, and its administration induces the innate immune response. In consequence, lipid-, polymer-, dendrimer-, and natural membrane-based mRNA drug delivery systems have been developed to deliver mRNA to target cells. Significant efforts and investments have been made to translate some of these systems into the clinic. Specifically, systemically administered lipid nanoparticles (LNPs) have delivered mRNA to the liver, and intramuscularly administered LNPs have delivered mRNA to immune cells to protect against coronavirus disease of 2019. However, clinically relevant delivery in non-liver tissues such as the spleen, lungs, heart, eye, central nervous system, and lymphatics requires improved drug delivery systems. In this Account, we provide an overview of key advances that have led us to Food and Drug Administration approval for the Pfizer/BioNTech mRNA-based vaccine against SARS-CoV-2 and Emergency Use Authorization for the Moderna mRNA-based vaccine against the same disease, and we explain how these developments will contribute to the clinical translation of mRNA therapeutics targeted outside of the liver. We first focus on the chemical modifications and sequence optimization that can improve the potency of mRNA, resulting in greatly improved pharmacokinetics. After detailing what makes an ideal mRNA payload, we review drug delivery systems used to deliver the payload into target cells. We describe efforts to reduce clearance by the liver, a key obstacle to the development of non-liver therapies. We then consider recent examples of nanoparticles that have delivered mRNA to non-liver tissues. Finally, we discuss current clinical mRNA programs, focusing on the COVID vaccines and highlighting lessons that may be applied to future mRNA drugs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Effective mRNA delivery to the central nervous system remains a formidable challenge.
“However, effective mRNA delivery to the central nervous system (CNS) remains a formidable challenge.”
From Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection (2025) · cites this paper as [5]
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · see citing works
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119 · see citing works
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281 · see citing works
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · see citing works
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047 · see citing works
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488 · see citing works
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383 · see citing works
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930 · see citing works
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912 · see citing works
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,771 · see citing works
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,766 · see citing works
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works
Distinct conformational states of SARS-CoV-2 spike protein
Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S. M., Walsh, R. M., Rawson, S., Rits-Volloch, S., & Chen, B. (2020) · Science · doi:10.1126/science.abd4251 · Cited by 1,221 · see citing works
Codon Optimality Is a Major Determinant of mRNA Stability
Presnyak, V., Alhusaini, N., Chen, Y.-H., Martin, S., Morris, N., Kline, N., Olson, S., Weinberg, D., Baker, K. E., Graveley, B. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.029 · Cited by 1,078 · see citing works
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works
Mechanism of hard-nanomaterial clearance by the liver
Tsoi, K. M., MacParland, S. A., Ma, X., Spetzler, V. N., Echeverri, J. A., Ouyang, B., Fadel, S. M., Sykes, E. A., Goldaracena, N., Kaths, J. M., et al. (2016) · Nature Materials · doi:10.1038/nmat4718 · Cited by 1,020 · see citing works
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014 · see citing works
Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.014 · Cited by 878 · see citing works
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P., DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., et al. (2021) · Nature · doi:10.1038/s41586-021-03534-y · Cited by 793 · see citing works
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 785 · see citing works
Principles for targeting RNA with drug-like small molecules
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.93 · Cited by 742 · see citing works
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., & Weisgraber, K. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47945-8 · Cited by 714 · see citing works
Liu, S., Cheng, Q., Wei, T., Yu, X., Johnson, L. T., Farbiak, L., & Siegwart, D. J. (2021) · Nature Materials · doi:10.1038/s41563-020-00886-0 · Cited by 653 · see citing works
Messenger RNA modifications: Form, distribution, and function
Gilbert, W. V., Bell, T. A., & Schaening-Burgos, C. (2016) · Science · doi:10.1126/science.aad8711 · Cited by 630 · see citing works
Wei, T., Cheng, Q., Min, Y.-L., Olson, E. N., & Siegwart, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17029-3 · Cited by 603 · see citing works
Elimination Pathways of Nanoparticles
Poon, W., Zhang, Y.-N., Ouyang, B., Kingston, B. R., Wu, J. L. Y., Wilhelm, S., & Chan, W. C. W. (2019) · ACS Nano · doi:10.1021/acsnano.9b01383 · Cited by 578 · see citing works
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541 · see citing works
Miller, J. B., Zhang, S., Kos, P., Xiong, H., Zhou, K., Perelman, S. S., Zhu, H., & Siegwart, D. J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610209 · Cited by 540 · see citing works
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Krienke, C., Kolb, L., Diken, E., Streuber, M., Kirchhoff, S., Bukur, T., Akilli-Öztürk, Ö., Kranz, L. M., Berger, H., Petschenka, J., et al. (2021) · Science · doi:10.1126/science.aay3638 · Cited by 520 · see citing works
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Lokugamage, M. P., Vanover, D. A., Beyersdorf, J. P., Hatit, M. Z. C., Rotolo, L., Echeverri, E. S., Peck, H. E., Ni, H., Yoon, J., Kim, Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00786-x · Cited by 507 · see citing works
Self-citationWang, F., Yu, L., Monopoli, M. P., Sandin, P., Mahon, E., Salvati, A. L., & Dawson, K. A. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.010 · Cited by 426 · see citing works
Segel, M., Lash, B., Song, J., Ladha, A., Liu, C. C., Jin, X., Mekhedov, S. L., Macrae, R. K., Koonin, E. V., & Zhang, F. (2021) · Science · doi:10.1126/science.abg6155 · Cited by 423 · see citing works
Qiu, M., Glass, Z., Chen, J., Haas, M., Jin, X., Zhao, X., Rui, X., Ye, Z., Li, Y., Zhang, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020401118 · Cited by 419 · see citing works
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
Patel, A. K., Kaczmarek, J. C., Bose, S., Kauffman, K. J., Mir, F. F., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201805116 · Cited by 383 · see citing works
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Rothgangl, T., Dennis, M. K., Lin, P. J. C., Oka, R., Witzigmann, D., Villiger, L., Qi, W., Hruzova, M., Kissling, L., Lenggenhager, D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00933-4 · Cited by 378 · see citing works
Liu, J., Chang, J., Jiang, Y., Meng, X., Sun, T., Mao, L., Xu, Q., & Wang, M. (2019) · Advanced Materials · doi:10.1002/adma.201902575 · Cited by 373 · see citing works
Orlandini von Niessen, A. G., Poleganov, M. A., Rechner, C., Plaschke, A., Kranz, L. M., Fesser, S., Diken, M., Löwer, M., Vallazza, B., Beissert, T., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.011 · Cited by 365 · see citing works
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620874114 · Cited by 335 · see citing works
Self-citationLipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA
Ball, R. L., Hajj, K. A., Vizelman, J., Bajaj, P., & Whitehead, K. A. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01101 · Cited by 314 · see citing works
Sago, C. D., Lokugamage, M. P., Paunovska, K., Vanover, D. A., Monaco, C. M., Shah, N. N., Gamboa Castro, M., Anderson, S. E., Rudoltz, T. G., Lando, G. N., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811276115 · Cited by 313 · see citing works
Self-citationCell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Veiga, N., Goldsmith, M., Granot, Y., Rosenblum, D., Dammes, N., Kedmi, R., Ramishetti, S., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-06936-1 · Cited by 308 · see citing works
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
Jiang, C., Mei, M., Li, B., Zhu, X., Zu, W., Tian, Y., Wang, Q., Guo, Y., Dong, Y., & Tan, X. (2017) · Cell Research · doi:10.1038/cr.2017.16 · Cited by 295 · see citing works
Paunovska, K., Sago, C. D., Monaco, C. M., Hudson, W. H., Castro, M. G., Rudoltz, T. G., Kalathoor, S., Vanover, D. A., Santangelo, P. J., Ahmed, R., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00432 · Cited by 277 · see citing works
Self-citationLipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272 · see citing works
Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262 · see citing works
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260 · see citing works
Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA
Patel, S., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., Mihai, C., Almarsson, Ö., & Sahay, G. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02664 · Cited by 251 · see citing works
Parhiz, H., Shuvaev, V. V., Pardi, N., Khoshnejad, M., Kiseleva, R. Y., Brenner, J. S., Uhler, T., Tuyishime, S., Mui, B. L., Tam, Y. K., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.015 · Cited by 233 · see citing works
Lindsay, K. E., Bhosle, S. M., Zurla, C., Beyersdorf, J., Rogers, K. A., Vanover, D., Xiao, P., Araínga, M., Shirreff, L. M., Pitard, B., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0378-3 · Cited by 218 · see citing works
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
Blanchard, E. L., Vanover, D., Bawage, S., Tiwari, P., Rotolo, L., Beyersdorf, J. P., Peck, H., Bruno, N. C., Hincapie, R., Michel, F., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00822-w · Cited by 212 · see citing works
Paunovska, K., Da Silva Sanchez, A. J., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201807748 · Cited by 205 · see citing works
Self-citationThe effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194 · see citing works
Marcos-Contreras, O. A., Greineder, C. F., Kiseleva, R. Y., Parhiz, H., Walsh, L. R., Zuluaga‐Ramirez, V., Myerson, J. W., Hood, E. D., Villa, C. H., Tombácz, I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912012117 · Cited by 187 · see citing works
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Zhang, X., Zhao, W., Nguyen, G. N., Zhang, C., Zeng, C., Yan, J., Du, S., Hou, X., Li, W., Jiang, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc2315 · Cited by 183 · see citing works
Mockey, M., Gonçalves, C., Dupuy, F. P., Lemoine, F. M., Pichon, C., & Midoux, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.105 · Cited by 165 · see citing works
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Jain, R., Frederick, J. P., Huang, E. Y., Burke, K. E., Mauger, D. M., Andrianova, E. A., Farlow, S. J., Siddiqui, S., Pimentel, J., Cheung-Ong, K., et al. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0734 · Cited by 164 · see citing works
Paunovska, K., Gil, C. J., Lokugamage, M. P., Sago, C. D., Sato, M., Lando, G. N., Gamboa Castro, M., Bryksin, A. V., & Dahlman, J. E. (2018) · ACS Nano · doi:10.1021/acsnano.8b03640 · Cited by 160 · see citing works
Self-citationConstrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
Lokugamage, M. P., Sago, C. D., Gan, Z., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902251 · Cited by 155 · see citing works
Self-citationLeveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., & Dong, Y. (2020) · Advanced Materials · doi:10.1002/adma.202004452 · Cited by 152 · see citing works
Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles
Hatit, M. Z. C., Lokugamage, M. P., Dobrowolski, C. N., Paunovska, K., Ni, H., Zhao, K., Vanover, D. A., Beyersdorf, J. P., Peck, H. E., Loughrey, D., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-021-01030-y · Cited by 149 · see citing works
Self-citationTheranostic barcoded nanoparticles for personalized cancer medicine
Yaari, Z. A., da Silva, D., Zinger, A., Goldman, E., Kajal, A., Tshuva, R., Barak, E., Dahan, N., Hershkovitz, D., Goldfeder, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13325 · Cited by 147 · see citing works
Guan, S., Munder, A., Hedtfeld, S., Braubach, P., Glage, S., Zhang, L., Lienenklaus, S., Schultze, A., Hasenpusch, G., Garrels, W., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0358-x · Cited by 130 · see citing works
Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution
Sago, C. D., Lokugamage, M. P., Islam, F. Z., Krupczak, B. R., Sato, M., & Dahlman, J. E. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08976 · Cited by 129 · see citing works
Self-citationMild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery
Lokugamage, M. P., Gan, Z., Zurla, C., Levin, J., Islam, F. Z., Kalathoor, S., Sato, M., Sago, C. D., Santangelo, P. J., & Dahlman, J. E. (2020) · Advanced Materials · doi:10.1002/adma.201904905 · Cited by 126 · see citing works
Self-citationBiodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., & Dong, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08163 · Cited by 107 · see citing works
Kauffman, K. J., Oberli, M. A., Dorkin, J. R., Hurtado, J. E., Kaczmarek, J. C., Bhadani, S., Wyckoff, J., Langer, R., Jaklenec, A., & Anderson, D. G. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.11.005 · Cited by 103 · see citing works
Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs
Li, Q., Chan, C. S., Peterson, N. C., Hanna, R. N., Alfaro, A., Allen, K. L., Wu, H., Dall’Acqua, W. F., Borrok, M. J., & Santos, J. L. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00003 · Cited by 103 · see citing works
A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA
Saunders, N., Paolini, M. S., Fenton, O. S., Poul, L., Devallière, J., Mpambani, F., Darmon, A., Bergère, M., Jibault, O., Germain, M., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00752 · Cited by 97 · see citing works
Wojtczak, B. A., Sikorski, P. J., Fac-Dabrowska, K., Nowicka, A. M., Warmiński, M., Kubacka, D., Nowak, E., Nowotny, M., Kowalska, J., & Jemielity, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02597 · Cited by 95 · see citing works
Kore, A. R., Shanmugasundaram, M., Charles, I., Vlassov, A. V., & Barta, T. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901655p · Cited by 90 · see citing works
mRNA secondary structure optimization using a correlated stem–loop prediction
Gaspar, P., Moura, G., Santos, M. A. S., & Oliveira, J. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1473 · Cited by 89 · see citing works
Tanaka, H., Nakatani, T., Furihata, T., Tange, K., Nakai, Y., Yoshioka, H., Harashima, H., & Akita, H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01084 · Cited by 82 · see citing works
Testing thousands of nanoparticles in vivo using DNA barcodes
Lokugamage, M. P., Sago, C. D., & Dahlman, J. E. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.001 · Cited by 81 · see citing works
Self-citationGan, Z., Lokugamage, M. P., Hatit, M. Z. C., Loughrey, D., Paunovska, K., Sato, M., Cristian, A., & Dahlman, J. E. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10161 · Cited by 75 · see citing works
Self-citationTreating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 72 · see citing works
Self-citationDelivery routes matter: Safety and efficacy of intratumoral immunotherapy
Lombaerde, E. D., Wever, O. D., & Geest, B. G. D. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188526 · Cited by 69 · see citing works
Devoldere, J., Peynshaert, K., Dewitte, H., Vanhove, C., Groef, L. D., Moons, L., Özcan, S. Y., Dalkara, D., Smedt, S. C. D., & Remaut, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.042 · Cited by 66 · see citing works
Szõke, D., Kovács, G., Kemecsei, É., Bálint, L., Ajtay, K., Aradi, P., Dinnyés, A. S., Mui, B. L., Tam, Y. K., Madden, T. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23546-6 · Cited by 64 · see citing works
Modified ARCA analogs providing enhanced translational properties of capped mRNAs
Kocmik, I., Piecyk, K., Rudzińska, M., Niedźwiecka-Kornaś, A., Darżynkiewicz, E., Grzela, R., & Jankowska‐Anyszka, M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1486164 · Cited by 57 · see citing works
Kowalska, J., del Nogal, A. W., Darżynkiewicz, Z. M., Buck, J., Nicola, C., Kuhn, A. N., Łukaszewicz, M., Zuberek, J., Strenkowska, M., Ziemniak, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku757 · Cited by 56 · see citing works
Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo
Sago, C. D., Lokugamage, M. P., Lando, G. N., Djeddar, N., Shah, N. N., Syed, C., Bryksin, A. V., & Dahlman, J. E. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03149 · Cited by 45 · see citing works
Self-citationEnhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides
Ray, R. M., Hansen, A. H., Taskova, M., Jandl, B., Hansen, J. T., Soemardy, C., Morris, K. V., & Astakhova, K. (2021) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.17.75 · Cited by 40 · see citing works
Li, M., Li, S., Huang, Y., Chen, H., Zhang, S., Zhang, Z., Wu, W., Zeng, X., Zhou, B., & Li, B. (2021) · Advanced Materials · doi:10.1002/adma.202101707 · Cited by 39 · see citing works
Increased PIP3 activity blocks nanoparticle mRNA delivery
Paunovska, K., Sanchez, A. D. S., Foster, M. T., Loughrey, D., Blanchard, E. L., Islam, F. Z., Gan, Z., Mantalaris, A., Santangelo, P. J., & Dahlman, J. E. (2020) · Science Advances · doi:10.1126/sciadv.aba5672 · Cited by 26 · see citing works
Self-citationMiwa, T., Saito, H., & Akita, H. (2021) · Experimental Brain Research · doi:10.1007/s00221-020-05970-0 · Cited by 26 · see citing works
Toki, N., Takahashi, H., Zucchelli, S., Gustincich, S., & Carninci, P. (2020) · FEBS Letters · doi:10.1002/1873-3468.13928 · Cited by 23 · see citing works
Barcoding chemical modifications into nucleic acids improves drug stability in vivo
Sago, C. D., Kalathoor, S., Fitzgerald, J. P., Lando, G. N., Djeddar, N., Bryksin, A. V., & Dahlman, J. E. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01642a · Cited by 22 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Chen, J., Ye, Z., Huang, C., Qiu, M., Song, D., Li, Y., & Xu, Q. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207841119 · Cited by 425 · see citing works
An, M., Raguram, A., Du, S. W., Banskota, S., Davis, J. R., Newby, G. A., Chen, P., Palczewski, K., & Liu, D. R. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02078-y · Cited by 275 · see citing works
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 237 · see citing works
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
Han, X., Gong, N., Xue, L., Billingsley, M. M., El-Mayta, R. D., Shepherd, S. J., Alameh, M., Weissman, D., & Mitchell, M. J. (2023) · Nature Communications · doi:10.1038/s41467-022-35637-z · Cited by 200 · see citing works
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Ni, H., Hatit, M. Z. C., Zhao, K., Loughrey, D., Lokugamage, M. P., Peck, H. E., Cid, A. D., Muralidharan, A., Kim, Y., Santangelo, P. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32281-5 · Cited by 192 · see citing works
Self-citationChemically Modified Platforms for Better RNA Therapeutics
Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00611 · Cited by 184 · see citing works
Drug delivery systems for CRISPR-based genome editors
Madigan, V. J., Zhang, F., & Dahlman, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00762-x · Cited by 180 · see citing works
Self-citationArtificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy
Witten, J. J., Raji, I. O., Manan, R. S., Beyer, E., Bartlett, S., Tang, Y., Ebadi, M., Lei, J., Nguyen, D., Oladimeji, F. A., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02490-y · Cited by 163 · see citing works
The use of RNA-based treatments in the field of cancer immunotherapy
Chehelgerdi, M., & Chehelgerdi, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01807-w · Cited by 146 · see citing works
Muskan, M., Abeysinghe, P., Cecchin, R., Branscome, H., Morris, K. V., & Kashanchi, F. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.025 · Cited by 142 · see citing works
Xue, L., Hamilton, A. G., Zhao, G., Xiao, Z., El-Mayta, R. D., Han, X., Gong, N., Xiong, X., Xu, J., Figueroa‐Espada, C. G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45422-9 · Cited by 142 · see citing works
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Hu, M., Li, X., You, Z., Cai, R., & Chen, C. (2023) · Advanced Materials · doi:10.1002/adma.202303266 · Cited by 133 · see citing works
Lipid carriers for mRNA delivery
Zhang, W., Jiang, Y., He, Y., Boucetta, H., Wu, J., Chen, Z., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.026 · Cited by 130 · see citing works
The roles of polymers in mRNA delivery
Huang, P., Deng, H., Zhou, Y., & Chen, X. S. (2022) · Matter · doi:10.1016/j.matt.2022.03.006 · Cited by 129 · see citing works
Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs
Luozhong, S., Yuan, Z., Sarmiento, T., Chen, Y., Gu, W., McCurdy, C., Gao, W., Li, R., Wilkens, S., & Jiang, S. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03234 · Cited by 128 · see citing works
Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114417 · Cited by 121 · see citing works
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Zhou, F., Huang, L., Li, S., Yang, W., Chen, F., Cai, Z., Liu, X., Xu, W., Lehto, V., Lächelt, U., et al. (2023) · Exploration · doi:10.1002/exp.20210146 · Cited by 115 · see citing works
Han, X., Alameh, M., Gong, N., Xue, L., Ghattas, M., Bojja, G., Xu, J., Zhao, G., Warzecha, C. C., Padilla, M. S., et al. (2024) · Nature Chemistry · doi:10.1038/s41557-024-01557-2 · Cited by 96 · see citing works
Frameworks for transformational breakthroughs in RNA-based medicines
Androsavich, J. R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00943-2 · Cited by 93 · see citing works
Fei, Y., Yu, X., Liu, P., Ren, H., Wei, T., & Cheng, Q. (2024) · Advanced Materials · doi:10.1002/adma.202409812 · Cited by 94 · see citing works
Petersen, D. M. S., Chaudhary, N., Arral, M. L., Weiss, R. M., & Whitehead, K. A. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.10.006 · Cited by 84 · see citing works
Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart
Radmand, A., Kim, H., Beyersdorf, J. P., Dobrowolski, C. N., Zenhausern, R., Paunovska, K., Huayamares, S. G., Hua, X., Han, K., Loughrey, D., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307801120 · Cited by 81 · see citing works
Self-citationKawaguchi, M., Noda, M., Ono, A., Kamiya, M., Matsumoto, M., Tsurumaru, M., Mizukami, S., Mukai, H., & Kawakami, S. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.12.026 · Cited by 81 · see citing works
Sanchez, A. J. D. S., Loughrey, D., Echeverri, E. S., Huayamares, S. G., Radmand, A., Paunovska, K., Hatit, M. Z. C., Tiegreen, K. E., Santangelo, P. J., & Dahlman, J. E. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304033 · Cited by 81 · see citing works
Self-citationOne‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells
Zhang, X., Su, K., Wu, S., Lin, L., He, S., Yan, X., Shi, L., & Liu, S. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405444 · Cited by 75 · see citing works
Paunovska, K., Sanchez, A. J. D. S., Lokugamage, M. P., Loughrey, D., Echeverri, E. S., Cristian, A., Hatit, M. Z. C., Santangelo, P. J., Zhao, K., & Dahlman, J. E. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03741 · Cited by 74 · see citing works
Self-citationRaguram, A., An, M., Chen, P., & Liu, D. R. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02467-x · Cited by 75 · see citing works
Lipid nanoparticles for mRNA delivery in brain via systemic administration
Cao, D., Hou, X., Wang, C., Wang, S., Liu, Z., Tian, M., Guo, K., Li, H., Kang, D. D., Zhong, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0730 · Cited by 73 · see citing works
The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo
Radmand, A., Lokugamage, M. P., Kim, H., Dobrowolski, C. N., Zenhausern, R., Loughrey, D., Huayamares, S. G., Hatit, M. Z. C., Ni, H., Cid, A. D., et al. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04479 · Cited by 71 · see citing works
Self-citationLipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
Mashima, R., & Takada, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100341 · Cited by 68 · see citing works
Huayamares, S. G., Lokugamage, M. P., Rab, R., Sanchez, A. J. D. S., Kim, H., Radmand, A., Loughrey, D., Lian, L., Hou, Y., Achyut, B. R., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.005 · Cited by 65 · see citing works
Self-citationTargeting materials and strategies for RNA delivery
Lin, L., Su, K., Cheng, Q., & Liu, S. (2023) · Theranostics · doi:10.7150/thno.87316 · Cited by 61 · see citing works
Zhou, Z., Wang, H., Li, J., Jiang, X., Li, Z., & Shen, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127911 · Cited by 54 · see citing works
Deciphering the Role of PEGylation on the Lipid Nanoparticle-Mediated mRNA Delivery to the Liver
Gao, M., Zhong, J., Liu, X., Zhao, Y., Zhu, D., Shi, X., Xu, X., Zhou, Q., Xuan, W., Zhang, Y., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c09399 · Cited by 52 · see citing works
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Seo, H., Jeon, L., Kwon, J., & Lee, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203033 · Cited by 51 · see citing works
Anand, P., Zhang, Y., Patil, S., & Kaur, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02528 · Cited by 51 · see citing works
Nonviral delivery systems for antisense oligonucleotide therapeutics
Huang, S. Q., Hao, X., Li, Y., Wu, J., Xiang, D., & Luo, S. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00292-4 · Cited by 50 · see citing works
Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
Lin, M., & Qi, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051450 · Cited by 51 · see citing works
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Huang, P., Deng, H., Wang, C., Zhou, Y., & Chen, X. S. (2023) · Advanced Materials · doi:10.1002/adma.202307822 · Cited by 49 · see citing works
Nucleic acid-based drugs for patients with solid tumours
Huayamares, S. G., Loughrey, D., Kim, H., Dahlman, J. E., & Sorscher, E. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00883-1 · Cited by 50 · see citing works
Self-citationUnlocking the promise of systemic STING agonist for cancer immunotherapy
Sun, X., Zhou, X., Lei, Y. L., & Moon, J. J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.047 · Cited by 47 · see citing works
On the mechanism of tissue-selective gene delivery by lipid nanoparticles
Kimura, S., & Harashima, H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.052 · Cited by 46 · see citing works
Peptide codes for organ-selective mRNA delivery
Chang, T., Zheng, Y., Jiang, M., Jia, S., Bai, J., Zheng, Z., Li, S., Guo, J., Wang, Y., Wang, Y., et al. (2025) · Nature Materials · doi:10.1038/s41563-025-02331-6 · Cited by 51 · see citing works
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles
Adlsadabad, S. Y., Hanrahan, J. W., & Kakkar, A. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031739 · Cited by 44 · see citing works
Petersen, D. M. S., Weiss, R. M., Hajj, K. A., Yerneni, S. S., Chaudhary, N., Newby, A. N., Arral, M. L., & Whitehead, K. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400225 · Cited by 44 · see citing works
Advanced nano-based strategies for mRNA tumor vaccine
Qu, Y., Xu, J., Zhang, T., Chen, Q., Sun, T., & Jiang, C. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.025 · Cited by 42 · see citing works
Dendritic Cell‐Mimicking Nanoparticles Promote mRNA Delivery to Lymphoid Organs
Cao, Y., Long, J., Sun, H., Miao, Y., Sang, Y., Lü, H., Yu, C., Zhang, Z., Wang, L., Yang, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202302423 · Cited by 42 · see citing works
Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology
Jacob, E. M., Huang, J., & Chen, M. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae017 · Cited by 46 · see citing works
Li, Z., Amaya, L., Ee, A., Wang, S. K., Ranjan, A., Waymouth, R. M., Chang, H. Y., & Wender, P. A. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c02704 · Cited by 41 · see citing works
Yao, Z., Liu, T., Wang, J., Fu, Y., Zhao, J., Wang, X., Li, Y., Yang, X., & He, Z. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108546 · Cited by 43 · see citing works
Fabry disease: Mechanism and therapeutics strategies
Li, X., Ren, X., Zhang, Y., Ding, L., Huo, M., & Li, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025740 · Cited by 43 · see citing works
Novel Ionizable Lipid Nanoparticles for SARS‐CoV‐2 Omicron mRNA Delivery
Long, J., Yu, C., Zhang, H., Cao, Y., Sang, Y., Lü, H., Zhang, Z., Wang, X., Wang, H., Song, G., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202590 · Cited by 36 · see citing works
Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles
Popoola, D. O., Cao, Z. L., Men, Y., Li, X., Viapiano, M. S., Wilkens, S., Luo, J., Teng, Y., Meng, Q., & Li, Y. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c01854 · Cited by 37 · see citing works
An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
Wu, S., Lin, L., Shi, L., & Liu, S. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1978 · Cited by 35 · see citing works
Zhao, Y., Tian, Z., Wang, J., Cui, M., Cao, Z., Liu, P., Li, R., Cai, S., Hu, Y., Ma, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady6460 · Cited by 35 · see citing works
Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection
Xue, Y., Wang, C., Li, H., Du, S., Zhong, Y., Zhang, Y., Wang, S., Guo, K., Hou, X., Kang, D. D., et al. (2025) · Advanced Materials · doi:10.1002/adma.202417097 · Cited by 34 · see citing works
Tailoring Highly Branched Poly(β-amino ester)s for Efficient and Organ-Selective mRNA Delivery
Yong, H., Lin, L., Li, Z., Guo, R. F., Wang, C., Liu, S., & Zhou, D. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c02440 · Cited by 34 · see citing works
Zwitterionic materials for nucleic acid delivery and therapeutic applications
He, S., & Liu, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.017 · Cited by 33 · see citing works
A Smart DNA‐Based Nanosystem Containing Ribosome‐Regulating siRNA for Enhanced mRNA Transfection
Lv, Z., Huang, M., Yang, J., Li, P., Chang, L., Tang, Q., Chen, X., Wang, S., Yao, C., Liu, P., et al. (2023) · Advanced Materials · doi:10.1002/adma.202300823 · Cited by 34 · see citing works
Gu, W., An, J., Li, Y., Yang, Y., Wang, S., Shan, H., Li, S., Li, H., Liu, G., Li, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202301686 · Cited by 32 · see citing works
Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery
Zeng, G., He, Z., Yang, H., Gao, Z., Ge, X., Liu, L., Liu, Z., & Chen, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02415 · Cited by 30 · see citing works
Biomimetic Triplet Messenger RNA Formulation in MXene Hydrogel Microneedles for Wound Healing
Wang, J., Wang, Y., Lu, M., Cao, X., Xia, M., Zhao, M., & Zhao, Y. (2024) · Aggregate · doi:10.1002/agt2.700 · Cited by 30 · see citing works
Antigen targeting to dendritic cells: Still a place in future immunotherapy?
Stoitzner, P., Romani, N., Rademacher, C., Probst, H. C., & Mahnke, K. (2022) · European Journal of Immunology · doi:10.1002/eji.202149515 · Cited by 29 · see citing works
Zhao, Y., Wang, Z. M., Song, D., Chen, M., & Xu, Q. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102499 · Cited by 28 · see citing works
Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy
Zhang, H., Liu, D., Yang, K., Liang, Z., & Li, M. (2025) · Science Advances · doi:10.1126/sciadv.adx5970 · Cited by 26 · see citing works
Poly(aspartic acid)-Based Polymeric Nanoparticle for Local and Systemic mRNA Delivery
Park, Y., Moses, A. S., Demessie, A. A., Singh, P., Lee, H., Korzun, T., Taratula, O. R., Alani, A. W. G., & Taratula, O. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00738 · Cited by 26 · see citing works
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
Li, Q., Zhang, L., Lang, J., Tan, Z., Feng, Q., Zhu, F., Liu, G., Ying, Z., Yu, X., Feng, H., et al. (2022) · Advanced Science · doi:10.1002/advs.202204334 · Cited by 25 · see citing works
CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
Cabré-Romans, J.-J., & Cuella-Martin, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1553590 · Cited by 28 · see citing works
Yong, H., Tian, Y., Li, Z., Wang, C., Zhou, D., Liu, J., Huang, X., & Li, J. (2025) · Advanced Materials · doi:10.1002/adma.202414991 · Cited by 24 · see citing works
Lipid nanoparticles deliver mRNA to the blood–brain barrier
Kuzminich, Y., Shakked, A., Calkins, R., Rudden, S., Jones, C., Doan, J., Jang, B., Echeverri, E. S., Zenhausern, R., Lian, L., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6827-7 · Cited by 23 · see citing works
Self-citationAdvancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems
Li, J., Zhang, Y., Yang, Y., & Sun, T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00276 · Cited by 23 · see citing works
Interaction design in mRNA delivery systems
Yu, M., Lin, L., Zhou, D., & Liu, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.038 · Cited by 23 · see citing works
Non‐Viral Gene Delivery Systems: Current Advances and Therapeutic Applications
Wang, F., Liang, L., Wang, C., Zhang, C., Ye, Y., Dou, L., Shi, L., Zhou, D., & Sun, X. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202500684 · Cited by 21 · see citing works
Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-Life
Arias, L. C. P., Huynh, D. N., Babity, S., Marleau, S., & Brambilla, D. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00086 · Cited by 21 · see citing works
Porosk, L., Härk, H. H., Arukuusk, P., Haljasorg, U., Peterson, P., & Kurrikoff, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030952 · Cited by 21 · see citing works
The clinical progress and challenges of mRNA vaccines
Yu, M., Wang, N., Zhu, J., & Lin, Y. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1894 · Cited by 22 · see citing works
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases
Huang, Y., Zhang, J., Wang, X., Jing, H., & Li, H. (2024) · Biomolecules · doi:10.3390/biom14080904 · Cited by 20 · see citing works
Lipid nanoparticle-mediated targeted mRNA delivery and its application in cancer therapy
Sui, Y., Hou, X., Zhang, J., Hong, X., Wang, H., Xiao, Y., & Zeng, X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01556a · Cited by 23 · see citing works
Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides
Wickline, S. A., Hou, K. K., & Pan, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119455 · Cited by 20 · see citing works
Suzuki, Y., Katsurada, Y., & Hyodo, K. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00547 · Cited by 21 · see citing works
Vosoughi, P., Naghib, S. M., Kangarshahi, B. M., & Mozafari, M. R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139532 · Cited by 20 · see citing works
In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery
Henser‐Brownhill, T., Martin, L., Samangouei, P., Ladak, A., Apostolidou, M., Nagel, B., & Kwok, A. (2024) · Advanced Science · doi:10.1002/advs.202401935 · Cited by 18 · see citing works
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses
Huayamares, S. G., Lian, L., Rab, R., Hou, Y., Radmand, A., Kim, H., Zenhausern, R., Achyut, B. R., Gilbert‐Ross, M., Lokugamage, M. P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58548-1 · Cited by 18 · see citing works
Self-citationEmerging mRNA Technology for Liver Disease Therapy
Wang, J., Fang, Y., Luo, Z., Wang, J., & Zhao, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c02987 · Cited by 19 · see citing works
Shin, H., Kang, S., Won, C., & Min, D. (2024) · Advanced Science · doi:10.1002/advs.202404590 · Cited by 18 · see citing works
Nucleic acid delivery by lipid nanoparticles for organ targeting
Guo, J., Gu, M., Chen, Y., Xiong, T., Zhang, Y., Chen, S., Li, M., Chen, X., & Peng, X. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110849 · Cited by 18 · see citing works
Qu, Y., Liu, R., Sun, D., & Dai, Z. (2024) · Materials Chemistry Frontiers · doi:10.1039/d4qm00479e · Cited by 17 · see citing works
Delivery of mRNA for cancer therapy: progress and prospects
Su, L.-J., Xu, M.-X., Ji, Z.-H., Zhu, J.-Q., Yu, M., Wang, Y., & Lin, Y. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102013 · Cited by 17 · see citing works
Exciting Times for Lipid Nanoparticles: How Canadian Discoveries Are Enabling Gene Therapies
Cheng, M. H. Y., Brimacombe, C. A., Verbeke, R., & Cullis, P. R. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00365 · Cited by 17 · see citing works
Cell-Derived Vesicles for mRNA Delivery
Li, Z., Liu, Z., Wu, J., & Li, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122699 · Cited by 16 · see citing works
Quaternization drives spleen-to-lung tropism conversion for mRNA-loaded lipid-like nanoassemblies
Huang, Y., Wu, J., Li, S., Liu, Z., Li, Z., Zhou, B., & Li, B. (2024) · Theranostics · doi:10.7150/thno.90071 · Cited by 16 · see citing works
One‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells
Zhang, X., Su, K., Wu, S., Lin, L., He, S., Yan, X., Shi, L., & Liu, S. (2024) · Angewandte Chemie · doi:10.1002/ange.202405444 · Cited by 16 · see citing works
Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
He, Z., Liu, Z., & Chen, Y. (2024) · ChemMedChem · doi:10.1002/cmdc.202400199 · Cited by 16 · see citing works
Branching in poly(amine-co-ester) polyplexes impacts mRNA transfection
Shin, K., Suh, H., Suberi, A., Whang, C., Ene, M., Grundler, J., Grun, M. K., & Saltzman, W. M. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122692 · Cited by 16 · see citing works
Nonsense Mutations in Rare and Ultra‐Rare Human Disorders: An Overview
Vitale, E., Ricci, D., Corrao, F., Fiduccia, I., Cruciata, I., Carollo, P. S., Branchini, A., Lentini, L., & Pibiri, I. (2025) · IUBMB Life · doi:10.1002/iub.70031 · Cited by 15 · see citing works
Glycolipid nanoparticles target the spleen and detarget the liver without charge
Gentry, K., Lian, L., Kim, H., Celik, O., Jones, C., Podilapu, A. R., Shakked, A., Loughrey, D., Zenhausern, R., Jang, B., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409569122 · Cited by 15 · see citing works
Self-citationNew trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery
Qi, Y., Xiong, W., Chen, Q., Ye, Z., Jiang, C., He, Y., & Ye, Q. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02011-0 · Cited by 15 · see citing works
Nanocarriers for inhaled delivery of RNA therapeutics
Huayamares, S. G., Zenhausern, R., & Loughrey, D. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100200 · Cited by 17 · see citing works
Self-citationGolden Threads of Lipid Nanoparticles (LNPs) contributing to COVID-19 mRNA Vaccine: A Review
Vasu, M., Yadav, P., Satyanarayana, Y., Ahlawat, J., Dulla, S., & Kumar, K. N. (2024) · BioNanoScience · doi:10.1007/s12668-024-01589-5 · Cited by 15 · see citing works
Wang, H., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70002 · Cited by 15 · see citing works
- Authors
- Loughrey, D., & Dahlman, J. E.
- Affiliations
- Georgia Institute of Technology (US)
- Corresponding author
- Dahlman, James E.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-12-03
- Volume
- 55
- Issue
- 1
- Pages
- 13-23
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W3215276910
- Cited by
- 173
- References
- 90
- Citations by year
- 2026: 33 · 2025: 40 · 2024: 51 · 2023: 30 · 2022: 19
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Accounts of Chemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- mRNA delivery, lipid nanoparticles, mRNA vaccines, SARS-CoV-2, sequence optimization, pharmacokinetics, nanoparticle drug delivery, intramuscular administration, innate immune response, mRNA therapeutics, clinical translation
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Humans, Liposomes, Liver, RNA, Messenger, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review